Jariwala 2018.

Study name	Adapting and expanding the Asthma‐Educator app
Methods	Design: open‐label randomised control trial Duration: endpoint at 16 weeks Setting: recruiting from primary and secondary care: outpatient primary and specialty care sites; trial conducted in United States
Participants	Population: 130 participants will be randomised to receive mobile application or usual care groups Age: range from 15 to 21 years Inclusion criteria: English‐speaking individuals between 15 and 21; persistent asthma (diagnosis made by a healthcare provider); on a daily controller medication; able to give informed consent; smartphone (iOS or Android) access Exclusion criteria: use of oral corticosteroids in the 2 weeks prior to the baseline visit; pregnancy; severe psychiatric or cognitive problems that would prohibit an individual from understanding and completing the protocol; patients that previously received the ASTHMA‐Educator application
Interventions	Intervention: Adapting and Expanding the Algorithmic Software Tool to Help Manage Asthma (ASTHAMXcel) for Youth with Asthma App: includes interactive games, educational videos, quizzes and personalised feedback. One‐way interaction with patient. There is adherence feedback. No co‐interventions (one digital component). Not a theory‐based intervention. Control: usual care group
Outcomes	Primary: asthma control Secondary: patient satisfaction; interface satisfaction; patient usage; ED visits; Asthma QoL; airway obstruction; medication adherence; health literacy; asthma knowledge; asthma symptom perception
Starting date	1 May 2018
Contact information	Contact: Sunit Jariwala, MD (718) 920‐4767 sjariwal@montefiore.org Contact: Obumneme Njeze, BS (973) 216‐1500 obumneme.njeze@einsteinmed.org
Notes	Type of publication: clinicaltrials.gov registry record only NCT03930381 Funding: Montefiore Medical Centre